FRIDAY, MAY 17, 2024 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for patients who have exhausted all other options to treat extensive-stage small cell lung cancer.Continue Reading

THURSDAY, May 16, 2024 (HealthDay News) — For anyone newly diagnosed with blood cancers known as lymphomas, their first question might be: What treatments can help? Of course, there have been big advances in chemotherapy against the disease, but treatments now go beyond chemo, said Mayo Clinic expert Dr. StephenContinue Reading